Fortress Biotech (FBIO) Assets (2010 - 2026)

Fortress Biotech's Assets history runs 16 years deep, the most recent figure standing at $185.5 million for Q4 2025.

• In Q4 2025, Assets rose 28.65% year-over-year to $185.5 million; the TTM figure through Dec 2025 stood at $185.5 million (up 28.65% YoY), while the FY2025 annual figure was $185.5 million, up 28.65% from the prior year.
• Assets for Q4 2025 stood at $185.5 million, up from $181.4 million in the prior quarter.
• The five-year high for Assets was $407.9 million in Q1 2022, with the low at $5.7 million in Q2 2021.
• The 5-year median for Assets is $181.1 million (2023), against an average of $232.0 million.
• The sharpest annual moves came in 2021 and 2022: Assets sank 97.88% in 2021, then jumped 6285.18% in 2022.
• Fortress Biotech's Assets stood at $396.5 million in 2021, then dropped by 25.78% to $294.3 million in 2022, then sank by 43.08% to $167.5 million in 2023, then fell by 13.91% to $144.2 million in 2024, then rose by 28.65% to $185.5 million in 2025.
• Business Quant data shows FBIO's Assets at $185.5 million in Q4 2025, $181.4 million in Q3 2025, and $159.9 million in Q2 2025.